Exercise Endurance

Comparison of anti-leukemic immunity against U937 cells in endurance athletes versus sedentary controls.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Comparison of anti-leukemic immunity against U937 cells in endurance athletes versus sedentary controls.

Abstract Source:

Int J Sports Med. 2000 Nov;21(8):602-7. PMID: 11156283

Abstract Author(s):

J Chiang, Y W Huang, M L Chen, S Y Wang, A C Huang, Y J Chen

Abstract:

To examine whether endurance athletes have higher anti-leukemic immunity than sedentary controls or not, we isolated peripheral blood mononuclear cells (MNC) from cyclists and sedentary controls to prepare conditioned media (CM) with various doses of phytohemagglutinin (PHA). The proliferation-inhibiting and differentiation-inducing activities of these PHA-MNC-CM on human leukemic U937 cells were investigated. Our results show that the growth inhibition activity of cyclists' PHA-MNC-CM were higher than that of controls. The dosage of PHA used to prepare MNC-CM to achieve about 90% growth inhibition was 5 microg/ml in the control group and was 2 microg/ml in the athletes group. The differentiation-inducing effects were evaluated by morphological scoring, superoxide production, and monocyte-associated antigen expression (CD14 and CD68). These three parameters all demonstrated the differentiation-inducing effect of MNC-CM increased with increasing dose of PHA. These effects were significantly greater in the athletic when compared to the sedentary control group at all doses of PHA. The levels of TNF-alpha and IFN-gamma PHA-MNC-CM increased in a PHA dose-dependent manner and were much higher in the athletic group when compared to the controls. We conclude that the capacity of endurance athletes to activate anti-leukemic immunity is significantly higher than that of sedentary controls.